Why did Abbott Laboratories delist from the London Stock Exchange?

Abbott Laboratories delisted from the London Stock Exchange to simplify its listing profile. This strategic decision is aimed at reducing administrative complexities and associated costs while maintaining liquidity on other major exchanges.

Will I be able to sell my Abbott shares after the London Stock Exchange delisting?

Yes, shareholders will still be able to buy and sell Abbott Laboratories' common shares. The stock continues to be listed on the New York Stock Exchange (NYSE), the Chicago Stock Exchange, and the SIX Swiss Exchange, ensuring continued trading and liquidity.

Does this delisting affect the value of my Abbott shares?

The delisting itself is primarily an administrative and strategic decision and is not expected to directly impact the fundamental value of Abbott's shares. The value will continue to be driven by the company's financial performance, business operations, and market conditions on its primary listing exchanges.

What are the implications for international investors who previously traded on the LSE?

International investors can continue to trade Abbott shares on the New York Stock Exchange (NYSE) or the SIX Swiss Exchange. While direct trading on the LSE is no longer possible, these alternative listings provide robust options for global investors.

ABT 8-K SEC Disclosure — Oct 24, 2016

Summary

Abbott Laboratories (ABT) announced on October 21, 2016, the completion of the cancellation of its common shares' listing on the London Stock Exchange. This strategic move is significant for investors as it streamlines the company's public listings, potentially reducing administrative complexities and associated costs. Despite the delisting from London, Abbott's common stock remains actively traded on major exchanges, including the New York Stock Exchange (NYSE), the Chicago Stock Exchange, and the SIX Swiss Exchange, ensuring continued liquidity and accessibility for shareholders.

Key Highlights

1Abbott Laboratories has successfully delisted its common shares from the London Stock Exchange (LSE) as of October 21, 2016.
2The delisting from the LSE is a strategic decision to simplify the company's listing profile.
3Abbott's common shares continue to be listed and traded on the New York Stock Exchange (NYSE).
4The company's shares also maintain their listing on the Chicago Stock Exchange.
5Abbott's common shares are also listed on the SIX Swiss Exchange, providing international trading options.
6This action is expected to streamline administrative processes and potentially reduce compliance costs.

ABBOTT LABORATORIES 8-K Report, Corporate Update (Oct 24, 2016)

Summary

Key Highlights

Frequently Asked Questions